News

Kroger’s QueVision ranks retailer among the top business technology innovators

BY Michael Johnsen

CINCINNATI — Kroger’s technology solution to speed up checkout wait times, called QueVision, has earned the company a No. 3 ranking in the InformationWeek Elite 100 — a list of the top business technology innovators in the United States, the company announced Wednesday. 

"Kroger is honored to be recognized for developing innovative technology solutions to meet customer needs — what we call Customer 1st innovation — in the InformationWeek Elite 100," stated Chris Hjelm, Kroger’s chief information officer. "What makes us most proud is how our associates — in Retail Operations and Kroger Technology, and store front-end managers, cashiers and courtesy clerks — worked together to both scale QueVision across more than 2,400 stores and to execute it so successfully."  

Kroger’s QueVision uses infrared sensors and predictive analytics to arm store front-end managers with real-time data to make sure registers are open when customers need them. As a result, the Kroger family of stores has reduced the time a customer waits in line to check out, on average, from four minutes before QueVision was deployed to less than 30 seconds today.

"Every day, we are returning precious minutes to our time-strapped customers by shortening the time they wait to checkout," said Marnette Perry, Kroger SVP strategic initiatives and operations. 

To view the complete ranking of InformationWeek Elite 100 winners, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Boots 1-of-7 companies to join CRN

BY Michael Johnsen

WASHINGTON — The Council for Responsible Nutrition on Wednesday announced the addition of seven new companies to its membership roster, including the Boots Co., which joined CRN as an international member. 

The other additions included voting members Arbonne International, Bergstrom Nutrition, HORN Nutraceuticals and SmartyPants, as well as associate members Jones Day and MCS Associates. 

“We are very pleased to welcome seven new companies to the CRN family,” stated Steve Mister, CRN president and CEO. “It is rewarding to see that companies are continuing to recognize the benefits of CRN membership, and we look forward to working with our new members to continue to strengthen a responsible industry.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Greer Labs gets FDA approval for Oralair

BY Ryan Chavis

LENOIR, N.C. — Greer Labs, a developer and provider of allergy immunotherapy products and services, announced that the Food and Drug Administration has approved Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablet.

Oralair is used for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for grass pollen-specific IgE antibodies for any of the five grass species contained in the product. It’s approved for people ages 10 years through 65 years.

Traditionally, allergy immunotherapy in the United States has been administered through a series of subcutaneous injections in an allergy specialist’s office. The approval of Oralair provides an additional option for allergy specialists and patients to consider when treating grass allergies.

“We are very pleased with the FDA’s approval of Oralair and believe it will provide a valuable treatment alternative for many patients with grass allergies,” said John G. Roby, Greer president and CEO. “Until now there has not been a sublingual allergy immunotherapy tablet available for grass allergic patients. As part of our dedication to advancing allergy immunotherapy, we look forward to launching Oralair with our partner Stallergenes and bringing this treatment option to patients here in the United States."  

Grass allergies are the most common seasonal allergy in the United States. Oralair is the only FDA-approved oral allergy immunotherapy tablets that includes a five grass, mixed pollens allergen extract, the company said, which provides a wide range of grass allergy coverage. The Oralair tablet dissolves under the tongue; the first dose is taken in the doctor’s office under medical supervision, with subsequent doses administered once a day by the patient or a caregiver.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES